Enfermedades Sistémicas de Base Autoinmune

Naredo, E; Acebes, C; Brito, E; de Agustin, JJ; de Miguel, E; Mayordomo, L; Moller, I; Moragues, C; Rejon, E; Rodriguez, A; Uson, J; Garrido, J; Martinez-Hernandez, D.

Three-dimensional Volumetric Ultrasound: A Valid Method for Blinded Assessment of Response to Therapy in Rheumatoid Arthritis

JOURNAL OF RHEUMATOLOGY. 2013; 40(3): 253-260 Nº de citas: 12 [doi:10.3899/jrheum.121103]

Naredo, E; Moller, I; Corrales, A; Bong, DA; Cobo-Ibanez, T; Corominas, H; Garcia-Vivar, ML; Macarron, P; Navio, T; Richi, P; Iagnocco, A; Garrido, J; Martinez-Hernandez, D.

Automated radiofrequency-based US measurement of common carotid intima-media thickness in RA patients treated with synthetic vs synthetic and biologic DMARDs

RHEUMATOLOGY. 2013; 52(2): 376-381 Nº de citas: 13 [doi:10.1093/rheumatology/kes260]

Ortea, I; Roschitzki, B; Ovalles, JG; Longo, JL; de la Torre, I; Gonzalez, I; Gomez-Reino, JJ; Gonzalez, A.

Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis

JOURNAL OF PROTEOMICS. 2012; 77: 372-382 Nº de citas: 45 [doi:10.1016/j.jprot.2012.09.011]

Cenit, MC; Simeon, CP; Vonk, MC; Callejas-Rubio, JL; Espinosa, G; Carreira, P; Blanco, FJ; Narvaez, J; Tolosa, C; Roman-Ivorra, JA; Gomez-Garcia, I; Garcia-Hernandez, FJ; Gallego, M; Garcia-Portales, R; Egurbide, MV; Fonollosa, V; de la Pena, PG; Lopez-Longo, FJ; Gonzalez-Gay, MA; Hesselstrand, R; Riemekasten, G; Witte, T; Voskuyl, AE; Schuerwegh, AJ; Madhok, R; Fonseca, C; Denton, C; Nordin, A; Palm, O; van Laar, JM; Hunzelmann, N; Distler, JHW; Kreuter, A; Herrick, A; Worthington, J; Koeleman, BP; Radstake, TRDJ; Martin, J.

Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis

JOURNAL OF RHEUMATOLOGY. 2012; 39(12): 2294-2302 Nº de citas: 31 [doi:10.3899/jrheum.120506]

Iagnocco, A; Naredo, E.

Osteoarthritis: research update and clinical applications

RHEUMATOLOGY. 2012; 51: 2-5 Nº de citas: 23 [doi:10.1093/rheumatology/kes328]

Aristimuno, C; Teijeiro, R; Valor, L; Alonso, B; Tejera-Alhambra, M; de Andres, C; Minarro, DO; Lopez-Lazareno, N; Faure, F; Sanchez-Ramon, S.

Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis

CLIN EXP MED. 2012; 12(4): 247-255 Nº de citas: 36 [doi:10.1007/s10238-011-0172-3]

Rivera, J; Rejas-Gutierrez, J; Vallejo, MA; Esteve-Vives, J; De Salas-Cansado, M.

Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2012; 30(6): 31-38 Nº de citas: 11

Valor, L; Sarmiento, E; Navarro, J; Gallego, A; Fernandez-Yanez, J; Fernandez-Cruz, E; Carbone, J.

Evaluation of Lymphoproliferative Responses by Carboxy Fluorescein Succinimidyl Ester Assay in Heart Recipients With Infections

TRANSPLANTATION PROCEEDINGS. 2012; 44(9): 2649-2652 Nº de citas: 4 [doi:10.1016/j.transproceed.2012.09.054]

Wakefield, RJ; D'Agostino, MA; Naredo, E; Buch, MH; Iagnocco, A; Terslev, L; Ostergaard, M; Backhaus, M; Grassi, W; Dougados, M; Burmester, GR; Saleem, B; de Miguel, E; Estrach, C; Ikeda, K; Gutierrez, M; Thompson, R; Balint, P; Emery, P.

After treat-to-target: can a targeted ultrasound initiative improve RA; outcomes?

POSTGRADUATE MEDICAL JOURNAL. 2012; 88(1042): 482-486 Nº de citas: 22 [doi:10.1136/postgradmedj-2011-201048rep]

Prior, N; Remor, E; Gomez-Traseira, C; Lopez-Serrano, C; Cabanas, R; Contreras, J; Campos, A; Cardona, V; Cimbollek, S; Gonzalez-Quevedo, T; Guilarte, M; de Rojas, DHF; Marcos, C; Rubio, M; Tejedor-Alonso, MA; Caballero, T.

Development of a disease-specific quality of life questionnaire for; adult patients with hereditary angioedema due to C1 inhibitor deficiency; (HAE-QoL): Spanish multi-centre research project

HEALTH AND QUALITY OF LIFE OUTCOMES. 2012; 10: Nº de citas: 59 [doi:10.1186/1477-7525-10-82]

de la Torre, I; Leandro, MJ; Edwards, JCW; Cambridge, G.

Baseline serum immunoglobulin levels in patients with rheumatoid arthritis: relationships with clinical parameters and with B-cell dynamics following rituximab

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2012; 30(4): 554-560 Nº de citas: 10

Tejera-Alhambra, M; Alonso, B; Teijeiro, R; Ramos-Medina, R; Aristimuno, C; Valor, L; de Andres, C; Sanchez-Ramon, S.

Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2012; 13(6): 6698-6710 Nº de citas: 18 [doi:10.3390/ijms13066698]

Wakefield, RJ; D'Agostino, MA; Naredo, E; Buch, MH; Iagnocco, A; Terslev, L; Ostergaard, M; Backhaus, M; Grassi, W; Dougados, M; Burmester, GR; Saleem, B; de Miguel, E; Estrach, C; Ikeda, K; Gutierrez, M; Thompson, R; Balint, P; Emery, P.

After treat-to-target: can a targeted ultrasound initiative improve RA; outcomes?

ANNALS OF THE RHEUMATIC DISEASES. 2012; 71(6): 799-803 Nº de citas: 94 [doi:10.1136/annrheumdis-2011-201048]

De La Torre, I; Leandro, MJ; Valor, L; Becerra, E; Edwards, JCW; Cambridge, G.

Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics

RHEUMATOLOGY. 2012; 51(5): 833-840 Nº de citas: 87 [doi:10.1093/rheumatology/ker417]

Vallejo, MA; Rivera, J; Esteve-Vives, J; Rodriguez-Munoz, MF.

Use of the Hospital Anxiety and Depression Scale (HADS) to evaluate anxiety and depression in fibromyalgia patients

REVISTA DE PSIQUIATRIA Y SALUD MENTAL. 2012; 5(2): 107-114 Nº de citas: 54 [doi:10.1016/j.rpsm.2012.01.003]

Gomez-Reino, JJ; Rodriguez-Lozano, C; Campos-Fernandez, C; Montoro, M; Descalzo, MA; Carmona, L.

Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0

ANNALS OF THE RHEUMATIC DISEASES. 2012; 71(3): 382-385 Nº de citas: 64 [doi:10.1136/annrheumdis-2011-200302]

Bello, IF; Alvarez, MT; Lopez-Longo, FJ; Arias-Salgado, EG; Martin, M; Jimenez-Yuste, V; de la Rua, AR; Butta, NV.

Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behcet disease patients

THROMBOSIS AND HAEMOSTASIS. 2012; 107(1): 88-98 Nº de citas: 25 [doi:10.1160/TH11-08-0556]

Lucia, CF; Rosa, RJM; Sagrario, PLM; Maria, MA; Maria, SS.

Effectiveness and Safety of Abatacept in Moderate to Severe Rheumatoid Arthritis

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. 2012; 15(1): 46-51 Nº de citas: 1